CRISPR Therapeutics › Investing in modestly sized growth stocks can lead to significant returns, but oftentimes it requires ...

List today: Adherex Technologies FENC is a clinical-stage biotechnology company which is focused on the development of Sodium ...

Shares of mid-cap oncology specialist Exelixis are worth about $39 each right now. The biotech generates steady revenue and ...

Healthcare and biotech stocks have lagged broader markets this year, but a growing number of names have been picking up steam ...

This year’s A-List shows that the revenues for the top five public companies in spatial biology have risen nine percent from a year ago ...

Summit Therapeutics Inc. (NASDAQ: SMMT) is one of the best biotech stocks with high potential. In a report released on ...

Many of the biotech stocks remain outside of Mr. Market's interest zone. Check out five biotech firms that may be of interest ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Biotech is outperforming the S&P 500 and NASDAQ as M&A heats up and Q4 tailwinds emerge, signaling more upside ahead. Read ...

More than 200 private U.S. biotechs with $50 million or more in funding to date secured their last reported financing between ...

Internet company The9 said Thursday its Singapore investee firm is expected to gain a Nasdaq listing and will have a roughly $1.5 billion pre-transaction equity value.